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Introduction
The NLRP3 sequence variant Q705K (Q703K) might have
an increased frequency in autoinflammatory conditions
including PFAPA and atypical cases of CAPS. It has also
been discussed as a modifier of inflammation in other
inflammatory conditions. We report the clinical picture
and laboratory findings in a patient with the homozygous
sequence variant Q705K in NLRP3.
Case Report
The patient, a 12-year-old boy with healthy parents,
experienced his first long febrile episode, associated with
abdominal pain, aseptic meningitis, spleenitis and
increased inflammatory markers, at the age of 2.5 years.
The patient was given corticosteroids, and responded well.
After the age of three years, the patient developed recur-
rent febrile episodes (approximately twice a year) with
abdominal pain of a duration exceeding 2 weeks, without,
skin rash and conjunctivitis. Corticosteroid treatment was
necessary to terminate the episodes. As steroids were
given early during the episodes, the full clinical picture is
not known, except for that the patient developed another
aseptic meningitis. The severity of the episodes increased
and today the patient depends on continuous steroid treat-
ment. Anakinra and colchicine has been used without
satisfactory response.
During febrile episodes, inflammatory markers including
SAA were elevated. Also, IL18 was increased while IgD
and IgA were normal.
The genes TNFSR1A and NLRP3 were screened and a
homozygous sequence variant, Q705K, was found in
NLRP3.
We have investigated cellular and molecular features
after the patient had developed fever, abdominal pain and
increased inflammatory markers, due to partial withdrawal
of corticosteroids. Analysing secretion of cytokines by
isolated monocytes incubated for 20 h, in the absence and
presence of LPS, we found that the patient produced less
IL10 as compared to parents/controls and that the
production of IP10 was decreased in both the patient and
the parents as compared to controls. The production of
IL1b and the monocyte caspase-1 activity were similar
between the patient and parents/controls. Also, the pro-
duction of IL6, IL8, IL12, IL17, GMCSF, INFg and TNFa
were similar. Neutrophil functions, including apoptosis,
degranulation and ROS production, were normal.
Discussion
The sequence variant Q705K in NLRP3 has been consid-
ered a polymorphism in its heterozygous form but might
also be a low-penetrance mutation. To our knowledge this
is the first description of a patient with a severe inflamma-
tory condition and a homozygote sequence variant
Q705K. The patient did not respond to IL1b blockade in
a moderate dose and IL1b mediation could not be
confirmed in our laboratory investigation. However, the
clinical unresponsiveness to IL1b blockade could be
related to the dose administered and the corticosteroids
may have influenced the laboratory results. It is probable
that the homozygous Q705K variant contributes to this
severe inflammatory condition in a multifactorial fashion,
as the phenotype otherwise would be much more com-
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